Journal
DIABETES
Volume 56, Issue 1, Pages 161-167Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db06-0310
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075040] Funding Source: NIH RePORTER
- NIDDK NIH HHS [R01 DK075040-03, R01 DK075040] Funding Source: Medline
Ask authors/readers for more resources
The CCAAT/enhancer-binding protein beta (C/EBP beta) is required for adipocyte differentiation and maturation. We have studied the role of the transcription factor, C/EBP beta, in the development of diet-induced obesity. Mice with a deletion in the gene for C/EBP beta (C/EBPP-/-) and wild-type mice were fed a high-fat diet (60% fat) for 12 weeks. The C/EBPP-/- mice lost body fat, whereas the wild-type mice increased their total body fat on a high-fat diet. The C/EBPP-/- mice had lower levels of blood triglycerides, free fatty acids, cholesterol, and hepatic triglyceride accumulation compared with the wild-type mice, thus protecting them from diet-induced obesity and fatty liver on a high-fat diet. Deletion of C/EBPP gene resulted in greatly reducing hepatic lipogenic genes, acetyl CoA carboxylase, and fatty acid synthase and increasing the expression of beta-oxidation genes in the brown adipose tissue. CO. production was significantly higher in the C/EBP beta(-/-) mice as was the level of uncoupling protein (UCP)-1 and UCP-3 in the muscle. In conclusion, the transcription factor C/EBPO is an important regulator in controlling lipid metabolism and in the development of diet-induced obesity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available